Lee A Y, Chung S K, Chung S S
Institute of Molecular Biology, University of Hong Kong.
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2780-4. doi: 10.1073/pnas.92.7.2780.
Aldose reductase (AR) has been implicated in the etiology of diabetic cataract, as well as in other complications. However, the role of AR in these complications remains controversial because the strongest supporting evidence is drawn from the use of AR inhibitors for which specificity in vivo cannot be ascertained. To settle this issue we developed transgenic mice that overexpress AR in their lens epithelial cells and found that they become susceptible to the development of diabetic and galactose cataracts. When the sorbitol dehydrogenase-deficient mutation is also present in these transgenic mice, greater accumulation of sorbitol and further acceleration of diabetic cataract develop. These genetic studies demonstrated convincingly that accumulation of polyols from the reduction of hexose by AR leads to the formation of sugar cataracts.
醛糖还原酶(AR)与糖尿病性白内障以及其他并发症的病因有关。然而,AR在这些并发症中的作用仍存在争议,因为最有力的支持证据来自于AR抑制剂的使用,而其体内特异性尚无法确定。为了解决这个问题,我们培育了在晶状体上皮细胞中过度表达AR的转基因小鼠,发现它们易患糖尿病性和半乳糖性白内障。当这些转基因小鼠同时存在山梨醇脱氢酶缺陷突变时,山梨醇会有更多积累,糖尿病性白内障的发展也会进一步加速。这些遗传学研究令人信服地证明,AR将己糖还原生成的多元醇积累会导致糖性白内障的形成。